cBio Cancer API Python Wrapper

116 views
Skip to first unread message

Sasha Dagayev

unread,
Jan 7, 2022, 9:13:31 AM1/7/22
to cbiop...@googlegroups.com
Hi!

I've developed a Python module for the cBioportal to make the data access a bit more seamless and have the return type of the data in a format that is more numpy/pandas friendly. 

The link and documentation is here: https://pypi.org/project/cbio-py/ 

I've integrated most of the data models but would love to chat with someone about making additional features. Is there a slack group or discord that exists for development?

Thank you!
-Sasha

debr...@mskcc.org

unread,
Jan 12, 2022, 9:56:15 AM1/12/22
to od...@nyu.edu, cbiop...@googlegroups.com

Hi Sasha!

 

Thanks for reaching out!

 

That looks like a great project! We have two slacks: one for internal development (I sent you an invite) and a public one that anyone can join w/o invite (https://slack.cbioportal.org)

 

For R we have a similar package called cBioPortalData which makes interacting with the API easier by providing a MultiAssayExperiment interface on top of the API. Your slack invite should add you to the channel where development on this package is discussed

 

We’re happy to link to your project from the documentation as well if you think that makes sense:

 

https://docs.cbioportal.org/6.-web-api-and-clients/api-and-api-clients

 

Best wishes,

Ino

--
You received this message because you are subscribed to the Google Groups "cBioPortal for Cancer Genomics Discussion Group" group.
To unsubscribe from this group and stop receiving emails from it, send an email to cbioportal+...@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/cbioportal/CAAJdZaBSgQKCAwF9u8edavSff5p%2BydJtbPEjptoKnYyhks2Vvw%40mail.gmail.com.



*** Only open attachments or links from trusted senders. Report phishing to inf...@mskcc.org ***

 

=====================================================================

Please note that this e-mail and any files transmitted from
Memorial Sloan Kettering Cancer Center may be privileged, confidential,
and protected from disclosure under applicable law. If the reader of
this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient,
you are hereby notified that any reading, dissemination, distribution,
copying, or other use of this communication or any of its attachments
is strictly prohibited. If you have received this communication in
error, please notify the sender immediately by replying to this message
and deleting this message, any attachments, and all copies and backups
from your computer.

Veera C.S.R. Chittepu

unread,
Dec 5, 2023, 3:03:50 PM12/5/23
to cBioPortal for Cancer Genomics Discussion Group
Great Work.
Reply all
Reply to author
Forward
0 new messages